Arrayit Diagnostics Licenses Ovarian Cancer Biomarkers from Wayne State U

Arrayit will use the biomarkers to develop and commercialize a microarray-based diagnostic test for early-stage ovarian cancer in women who are not yet symptomatic.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.